Scholar Rock submitted its BLA of apitegromab for the treatment of patients with Spinal Muscular Atrophy with a request for ...

We recently compiled a list of the 12 Stocks That Will Double in 2025. In this article, we are going to take a look at where ...

Dilafor has completed interactions with US and European authorities during 2023 – 2024 to achieve an alignment in the regulatory process ahead of the upcoming clinical phase 3 trials with the ...

The cardiac pacemaker market has witnessed significant growth over recent years, driven by the increasing prevalence of heart diseases, advancements in pacemaker technology, and growing awareness ...

The US dollar is looking at the nonsense at the FOMC press conference from the previous session, as well as a cooler than expected Advanced GDP in the US.